Step-wise, two sequential, single-dose, bioequivalence study in 12 healthy volunteers to
determine whether crushed Genvoya tablet is bioequivalent to whole Genvoya tablet. The first
study sequence will involve a directly observed single dose of the fixed dose formulation of
whole Genvoya tablet, with semi-intensive pharmacokinetic serum sampling at time points
following the dose. After a washout period of seven days, subjects will then receive a
directly observed single dose of a crushed tablet of Genvoya with subsequent semi-intensive
pharmacokinetic serum sampling.